Skip to main content
. 2019 Aug 27;10(20):4860–4865. doi: 10.7150/jca.32675

Table 4.

Associations between the 2 SNPs in MAGE-A11 gene and RCC patients' survival.

rs6641352 (T/C) Patients/deaths 5-year survival (%)a Log-rank P Crude HR (95% CI) HR (95% CI)b Pb
Total number of subjects 308/32 80
Codominant model
TT 191/17 81 1.000 (reference) 1.000 (reference)
TC 104/9 86 0.554 0.803 (0.353-1.823) 0.753 (0.291-1.953) 0.560
CC 13/6 —— 0.001 4.193 (1.635-10.757) 3.217 (0.940-11.013) 0.063
P trend 0.079
Additive model 0.001 1.625 (0.940-2.809) 1.415 (0.773-2.592) 0.261
Dominant model
TT 191/17 81 1.000 (reference) 1.000 (reference)
TC/CC 117/15 79 0.653 0.636 (0.584-2.410) 1.110 (0.488-2.523) 0.804
Recessive model
TT/TC 295/26 83 1.000 (reference) 1.000 (reference)
CC 13/6 —— <0.001 4.569 (1.870-11.161) 3.526 (1.072-11.595) 0.038

BMI, body mass index; HR, hazard ratio.

Values in bold indicate statistically different.

aProportion of survival derived from Kaplan-Meier analysis.

bAdjusted for age, sex, BMI, smoking status, drinking status, hypertension, diabetes and family history of cancer, clinical stage, tumor stage and histology in Cox regression model.